1-4 of 4
Man Li
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer

Yunkai Qie, Shiwang Huang, Chong Shen, Zhouliang Wu, La Da, Kaipeng Jia, Zhe Zhang, Gangjian Zhao, Lili Wang, Guoping Xu, Yang Zhao, Rui Liang, Jianing Guo, Changping Li, Hua Dong, Man Li, Hongjun Li, Houyuan Chen, Dawei Tian, Changli Wu, Wei Zhang, Zesheng An, Haitao Wang, Yuanjie Niu, Hailong Hu
Journal: Clinical Cancer Research
Clin Cancer Res (2025)
https://doi.org/10.1158/1078-0432.CCR-24-3321
Published: 07 January 2025
View article titled, Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer
Open the PDF for Phase 2 pilot trial of tislelizumab plus low-dose nab-paclitaxel for extensive very high-risk non-muscle-invasive bladder cancer in another window
Includes: Supplementary data
Journal Articles

Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma

Miaoling Tang, Shuxia Zhang, Meisongzhu Yang, Rongni Feng, Jinbin Lin, Xiaohong Chen, Yingru Xu, Ruyuan Yu, Xinyi Liao, Ziwen Li, Xincheng Li, Man Li, Qiliang Zhang, Suwen Chen, Wanying Qian, Yuanji Liu, Libing Song, Jun Li
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (10): 2206–2224.
https://doi.org/10.1158/1078-0432.CCR-23-2933
Published: 15 May 2024
View article titled, Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma
Open the PDF for Infiltrative Vessel Co-optive Growth Pattern Induced by IQGAP3 Overexpression Promotes Microvascular Invasion in Hepatocellular Carcinoma in another window
Includes: Supplementary data
Journal Articles

RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition

Lisa Hunihan, Dejian Zhao, Heather Lazowski, Man Li, Yuping Qian, Laura Abriola, Yulia V. Surovtseva, Viswanathan Muthusamy, Lynn T. Tanoue, Bonnie E. Gould Rothberg, Kurt A. Schalper, Roy S. Herbst, Frederick H. Wilson
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (14): 3091–3103.
https://doi.org/10.1158/1078-0432.CCR-21-4291
Published: 15 July 2022
View article titled, RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition
Open the PDF for RASGRF1 Fusions Activate Oncogenic RAS Signaling and Confer Sensitivity to MEK Inhibition in another window
Includes: Supplementary data
Journal Articles

Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy

Yan Nie, Hongyan Huang, Mingyan Guo, Jiewen Chen, Wei Wu, Wende Li, Xiaoding Xu, Xiaorong Lin, Wenkui Fu, Yandan Yao, Fang Zheng, Man-Li Luo, Phei Er Saw, Herui Yao, Erwei Song, Hai Hu
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (13): 3873–3886.
https://doi.org/10.1158/1078-0432.CCR-18-3421
Published: 01 July 2019
View article titled, Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy
Open the PDF for Breast Phyllodes Tumors Recruit and Repolarize Tumor-Associated Macrophages via Secreting CCL5 to Promote Malignant Progression, Which Can Be Inhibited by CCR5 Inhibition Therapy in another window
Includes: Supplementary data